The Online Investor
Home
Dividends
25 Safe Dividends
Stock Splits
Mergers & Acquisitions
Mega Mergers
Stock Buybacks
Stock Buybacks
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
IPOs
Secondary Offerings
Top 20 Large Caps
Top 20 Biggest ETFs
Insider Buying
Top 25 Low PE Ratios
Analyst Actions
25 Top Analyst Picks
Articles
CAGR Calculator
Dunnan On Dollars
10 Pot Stocks
ETF Center
Knowledge Center
Retirement Center
Advertising Opportunities
Privacy Policy
Disclaimer Statement
MEDP Buyback image

Medpace Holdings, Inc. Buyback

OLI recorded this information on 8/16/2017

Company: Medpace Holdings, Inc.
Buyback: MEDP buyback
Share Amount Authorized: 2,000,000
Buyback Details: Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced it has entered into a stock repurchase agreement (the "Stock Repurchase Agreement") with investment funds affiliated with Cinven Capital Management (V) General Partner Limited ("Cinven"). Under the terms of the Stock Repurchase Agreement with Cinven, Medpace has agreed to repurchase 2,000,000 shares of Medpace's common stock, at a purchase price of $30.27 per share, representing aggregate consideration of approximately $60.5 million. The transaction is expected to close on or about August 18, 2017, subject to customary closing conditions.

Medpace Holdings is a holding company. Through its subsidiaries, Co. is a global provider of clinical research-based drug and medical device development services. Co. provides a suite of services supporting the entire clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s clinical development services include medical department, clinical trial management, data-driven feasibility, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, main laboratory, central laboratory, bioanalytical laboratory, clinics and quality assurance.

MEDP SEC Filing Email Alerts Service

Open the MEDP Page at The Online Investor »

MEDP — Key Stats (updated 6 hours, 54 minutes ago)
Company Name:  Medpace Holdings Inc
Stock buyback:  MEDP buyback
Website:  www.medpace.com
Sector:  Biotechnology
Number of ETFs Holding MEDP:  68
Total Market Value Held by ETFs:  $1.71B
Total Market Capitalization:  $12.52B
% of Market Cap. Held by ETFs:  13.61%
 

Open the MEDP Page at The Online Investor (in a new window) »
April 25, 2024  •  6:22 PM Eastern
MEDP — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree MEDP Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Avg. Broker Rec.

Strong Buy (3.67 out of 4)
66th percentile
(ranked higher than approx. 66% of all stocks covered)

Analysts' Target Price:
MEDP Stock Forecast

 Based on Zacks ABR data;
powered by Xignite

MEDP Buyback | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.